Single award · contract

Production of Therapeutic in Support of National Emergency Response to Coronavirus 2019 (COVID-19): IN…

Award ID: W15QKN21C0014

FY2021 · complete year · data as of 2026-07-12

A single federal award, with both ends of the trail linked.

$5.6B
Total award value

Award W15QKN21C0014 is a contract from the Department of Defense to Regeneron Pharmaceuticals Inc, $5.6B obligated, FY2021 to FY2022, for Production of Therapeutic in Support of National Emergency Response to Coronavirus 2019 (COVID-19)…. The work is performed in New York. It is classified as PSC 6505 (Drugs and Biologicals) and NAICS 325414 (Biological Product (except Diagnostic) Manufacturing). Source

Agency ›
Department of Defense
Source
awarded→$5.6B
Recipient ›
Regeneron Pharmaceuticals Inc
Source
performed in→
State ›
New York
Source

Description

Production of Therapeutic in Support of National Emergency Response to Coronavirus 2019 (COVID-19): IN Support of Operation Warp Speed (OWS), the Government Is Purchasing Up to 1,250,000 Doses of the Emergency Use Authorization (EUA) Therapeutic.

Award details

Award typeContract
PIIDW15QKN21C0014
Action date2021
Period18 mo
Awarding agencyDepartment of Defense →
RecipientRegeneron Pharmaceuticals Inc →
Place of performanceNew York →
CategoryPSC 6505NAICS 325414
Competed?Not recordedSource
Total (exact)$5,565,000,000

More awards to Regeneron Pharmaceuticals Inc

Contract HHSO100201700016C
awarded 2017$973.6M
Regeneron Other Transaction Authority (OTA) Award
awarded 2017$278.8M
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
SSN 802 and 803 Long Lead Time Material
awarded 2017$35.7B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.